Free Trial
NASDAQ:TFFP

TFF Pharmaceuticals (TFFP) Stock Price, News & Analysis

TFF Pharmaceuticals logo
$0.06 0.00 (0.00%)
As of 04/10/2025

About TFF Pharmaceuticals Stock (NASDAQ:TFFP)

Key Stats

Today's Range
$0.07
$0.07
50-Day Range
$0.07
$0.07
52-Week Range
$0.06
$3.23
Volume
N/A
Average Volume
958,120 shs
Market Capitalization
$288.60 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TFFP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TFF Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

TFFP Stock News Headlines

TFF Pharmaceuticals approves dissolution plan
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
TFF Pharmaceuticals Shares Fall 66%; Company to Wind Down
TFF Pharmaceuticals terminates employees, to wind down operations
TFF Pharmaceuticals to Dissolve and Liquidate Assets
TFF Pharmaceuticals Announces It Will Wind Down Operations
See More Headlines

TFFP Stock Analysis - Frequently Asked Questions

TFF Pharmaceuticals' stock was trading at $0.0650 on January 1st, 2025. Since then, TFFP stock has increased by 0.0% and is now trading at $0.0650.

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) posted its quarterly earnings data on Wednesday, November, 20th. The company reported ($0.81) earnings per share for the quarter.

TFF Pharmaceuticals's stock reverse split on the morning of Tuesday, December 19th 2023.The 1-25 reverse split was announced on Tuesday, December 19th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, December 19th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

TFF Pharmaceuticals (TFFP) raised $22 million in an initial public offering (IPO) on Friday, October 25th 2019. The company issued 4,400,000 shares at $5.00 per share. National Securities served as the underwriter for the IPO.

Shares of TFFP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that TFF Pharmaceuticals investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), CymaBay Therapeutics (CBAY), GE Aerospace (GE), CrowdStrike (CRWD) and Adobe (ADBE).

Company Calendar

Last Earnings
11/20/2024
Today
7/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TFFP
CIK
1733413
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$730 thousand
Price / Cash Flow
N/A
Book Value
$4.04 per share
Price / Book
0.02

Miscellaneous

Free Float
4,244,000
Market Cap
$288.60 thousand
Optionable
Optionable
Beta
0.98
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:TFFP) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners